Enovix/$ENVX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Enovix
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.
- Ticker
- $ENVX
- Sector
- Industrials
- Primary listing
- NASDAQ
- Employees
- 664
- Headquarters
- Fremont, United States
- Website
- www.enovix.com
Enovix Metrics
BasicAdvanced
$301M
-
-$0.73
2.39
-
Price and volume
Market cap
$301M
Beta
2.39
52-week high
$9.19
52-week low
$1.28
Average daily volume
11M
Financial strength
Current ratio
9.096
Quick ratio
8.479
Long term debt to equity
3.08
Total debt to equity
3.171
Interest coverage (TTM)
-6.41%
Profitability
EBITDA (TTM)
-131.405
Gross margin (TTM)
22.31%
Net profit margin (TTM)
-406.54%
Operating margin (TTM)
-436.12%
Effective tax rate (TTM)
0.37%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-12.72%
Return on equity (TTM)
-67.61%
Valuation
Price to revenue (TTM)
7.949
Price to book
1.83
Price to tangible book (TTM)
2.42
Price to free cash flow (TTM)
-2.402
Free cash flow yield (TTM)
-41.62%
Free cash flow per share (TTM)
-0.591
Growth
Revenue change (TTM)
28.59%
Earnings per share change (TTM)
-12.79%
3-year revenue growth (CAGR)
206.20%
3-year earnings per share growth (CAGR)
-17.21%
What the Analysts think about Enovix
Analyst ratings (Buy, Hold, Sell) for Enovix stock.
Analyst projections of the future price of Enovix stock.
Bulls say / Bears say
Commercial demand is beginning to turn into firm orders: Enovix secured a 100,000-battery drone order for first-half 2027 delivery and a separate initial production order for its MX1-B01 cell after successful field trials. (Enovix, GlobeNewswire)
Q3 revenue was $11 million, up 38% year on year and above the $9 million–$10 million guidance range, marking the sixth consecutive quarter of year-on-year growth. (GlobeNewswire)
Enovix retired $128 million face value of 2030 notes for $81.4 million, reducing debt by $46.6 million, and cut annual costs by about $8.5 million through restructuring. These steps lower its cost base as it shifts resources towards the Korean business. (GlobeNewswire)
The smartphone programme has suffered a setback: Enovix said its pre-AI-2 cell did not meet the latest energy-density target, so it will not proceed to system-level field testing with those units and is focusing silicon-anode development on smart eyewear. (GlobeNewswire)
Near-term sales guidance has weakened: Q4 revenue is forecast at $9 million–$10 million, 12%–20% below the prior-year quarter’s $11.3 million, despite Q3 growth. (GlobeNewswire)
Enovix is still burning substantial cash: Q3 operating cash outflow was about $29.2 million and free cash flow was negative $33.1 million, while Q4 non-GAAP operating losses are forecast at $28 million–$31 million. (Quantisnow, GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 12 Nov 2026.
Enovix Financial Performance
Revenues and expenses
Enovix Earnings Performance
Company profitability
Upcoming events
No upcoming events
Enovix News
AllArticlesVideos

Block & Leviton Seeks Enovix Investors After 37% Two-Day Drop
Newsfile Corp1 day ago

Lost Money on Enovix Corporation Shares? The Law Offices of Frank R.
Business Wire4 days ago

Lost Money on Enovix Corporation Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.66% Share Price Drop
Business Wire5 days ago
Funds containing Enovix
Fund name | Fund size | $ENVX weighting |
|---|---|---|
iShares Lithium & Battery Producers£LITM | $43M | 0.27% |
SPDR Russell 2000 US Small Cap€R2US | $4.7B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | $4.7B | 0.01% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $2.7B | 0.01% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $2.7B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.